Recently, a study on the critical value of genetic prion diseases (gPrD) cerebrospinal fluid markers showed that although the amount of Tau protein in the cerebrospinal fluid of patients with FFI is lower than that of sCJD, its elevated level still has diagnostic significance. The gene discussed is MAPT; the disease is prion disease.